ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print
COVID vaccines

WHO approves Sinovac COVID-19 vaccine for emergency use

Second Chinese vaccine gets green light as agency pushes for global access

Sinovac's CoronaVac COVID-19 vaccine is the second from China to be approved by the WHO.   © Reuters

SHANGHAI -- The World Health Organization on Tuesday approved the second Chinese COVID-19 vaccine for emergency use, providing a possible boost to its global access initiative as concerns about trial data linger.

Sinovac Biotech's CoronaVac joined Sinopharm and five other Western vaccines recognized by the WHO, which is trying to meet the global demand for inoculation.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more